UK Healthcare Policy: Devon Partnership NHS Trust became England’s first NHS trust to formalize inpatient medical cannabis procedures, setting rules for verifying legally prescribed products, storage, and administration during admissions. US Federal Cannabis Push: Senate Democrats reintroduced the Cannabis Administration and Opportunity Act to remove cannabis from the Controlled Substances Act, aiming to expand research access and reduce federal enforcement fallout. State/Local Cannabis Rollout: Hanover County, Virginia, moved to draft local ordinances for the state’s upcoming retail cannabis market, with local input tied to licensing decisions ahead of 2027. Medical Cannabis Access & Pain: Medigrowth partnered with Chronic Pain Australia for National Pain Week, citing survey data showing growing use and interest in medicinal cannabis for chronic pain management. CBD Consumer Market: A new report projects rapid growth for hemp-infused seltzers, driven by demand for alcohol-free wellness drinks featuring CBD and hemp-derived ingredients. Hemp Product Regulation: A US bill would regulate hemp products instead of banning them, reflecting ongoing policy fights over THC-containing hemp goods. Research/Clinical Angle: Coverage highlights mixed results in supplement science, including how omega-3 trials often fail to deliver cognition benefits—useful context for how CBD claims may be scrutinized. Agriculture & Weed Control (Indirect): UK farming coverage stresses stronger pre-emergence herbicide programs and warns about herbicide carryover into cover crops, underscoring the broader weed-management backdrop for hemp and CBD supply chains.